Evidence map›Paper›PMID 36248019›Full record

ArticleFrontiers in medical technology2022

Medical decision support system using weakly-labeled lung CT scans.

Alejandro Murillo-González, David González, Laura Jaramillo, Carlos Galeano, Fabby Tavera, Marcia Mejía, Alejandro Hernández, David Restrepo Rivera, J G Paniagua, Leandro Ariza-Jiménez and 10 more

Abstract read
In one paragraph

Article in Frontiers in medical technology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alejandro Murillo-GonzálezDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
David GonzálezRadiology Department, Universidad CES, Medellín, Colombia.
Laura JaramilloRadiology Department, Universidad CES, Medellín, Colombia.
Carlos GaleanoRadiology Department, Universidad CES, Medellín, Colombia.
Fabby TaveraRadiology Department, Universidad de Antioquia, Medellín, Colombia.
Marcia MejíaRadiology Department, Universidad de Antioquia, Medellín, Colombia.
Alejandro HernándezInstitución Prestadora de Servicios de Salud IPS Universitaria, Medellín, Colombia.
David Restrepo RiveraDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
J G PaniaguaInstituto Tecnológico Metropolitano, Medellín, Colombia.
Leandro Ariza-JiménezDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
José Julián Garcés EcheverriDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Christian Andrés Diaz LeónDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Diana Lucia Serna-HiguitaDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Wayner BarriosWiqonn Technologies, Barranquilla, Colombia.
Wiston ArrázolaDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Miguel Ángel MejíaDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Sebastián ArangoDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Daniela Marín RamírezDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.
Emmanuel Salinas-MirandaLunefield Institute, Mount Sinai, Toronto, Canada.
O L QuinteroDepartment of Mathematical Sciences, Universidad EAFIT, Medellín, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Determination and development of an effective set of models leveraging Artificial Intelligence techniques to generate a system able to support clinical practitioners working with COVID-19 patients. It involves a pipeline including classification, lung and lesion segmentation, as well as lesion quantification of axial lung CT studies. Approach: A deep neural network architecture based on DenseNet is introduced for the classification of weakly-labeled, variable-sized (and possibly sparse) axial lung CT scans. The models are trained and tested on aggregated, publicly available data sets with over 10 categories. To further assess the models, a data set was collected from multiple medical institutions in Colombia, which includes healthy, COVID-19 and patients with other diseases. It is composed of 1,322 CT studies from a diverse set of CT machines and institutions that make over 550,000 slices. Each CT study was labeled based on a clinical test, and no per-slice annotation took place. This enabled a classification into Normal vs. Abnormal patients, and for those that were considered abnormal, an extra classification step into Abnormal (other diseases) vs. COVID-19. Additionally, the pipeline features a methodology to segment and quantify lesions of COVID-19 patients on the complete CT study, enabling easier localization and progress tracking. Moreover, multiple ablation studies were performed to appropriately assess the elements composing the classification pipeline. Results: The best performing lung CT study classification models achieved 0.83 accuracy, 0.79 sensitivity, 0.87 specificity, 0.82 F1 score and 0.85 precision for the Normal vs. Abnormal task. For the Abnormal vs COVID-19 task, the model obtained 0.86 accuracy, 0.81 sensitivity, 0.91 specificity, 0.84 F1 score and 0.88 precision. The ablation studies showed that using the complete CT study in the pipeline resulted in greater classification performance, restating that relevant COVID-19 patterns cannot be ignored towards the top and bottom of the lung volume. Discussion: The lung CT classification architecture introduced has shown that it can handle weakly-labeled, variable-sized and possibly sparse axial lung studies, reducing the need for expert annotations at a per-slice level. Conclusions: This work presents a working methodology that can guide the development of decision support systems for clinical reasoning in future interventionist or prospective studies.

Indexed as

computational tomographylesion segmentation / quantificationmachine learningvolume classificationweak-labels

Identifiers

PMID36248019
PMCPMC9554434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.